Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal ...
As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN® Nasal Spray and build on its longstanding
Source: eagletribune.com